Cargando…
Pathway-Centric Structure-Based Multi-Target Compound Screening for Anti-Virulence Drug Repurposing
The emergence of superbugs that are resistant to last-resort antibiotics poses a serious threat to human health, and we are in a “race against time to develop new antibiotics.” New approaches are urgently needed to control drug-resistant pathogens, and to reduce the emergence of new drug-resistant m...
Autores principales: | Xie, Li, Xie, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678309/ https://www.ncbi.nlm.nih.gov/pubmed/31319464 http://dx.doi.org/10.3390/ijms20143504 |
Ejemplares similares
-
Drug repurposing to target Ebola virus replication and virulence using structural systems pharmacology
por: Zhao, Zheng, et al.
Publicado: (2016) -
Target-specific compound selectivity for multi-target drug discovery and repurposing
por: Wang, Tianduanyi, et al.
Publicado: (2022) -
COVID-19 Multi-Targeted Drug Repurposing Using Few-Shot Learning
por: Liu, Yang, et al.
Publicado: (2021) -
Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs
por: Lipinski, Christopher A., et al.
Publicado: (2022) -
Insights into bioinformatic approaches for repurposing compounds as
anti-viral drugs
por: Zheng, Wenxiao, et al.
Publicado: (2021)